These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 28435908
1. Development of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes. Matsuda S, Nerome R, Maegawa K, Kotaki A, Sugita S, Kawasaki K, Kuroda K, Yamaguchi R, Takasaki T, Nerome K. Heliyon; 2017 Apr; 3(4):e00286. PubMed ID: 28435908 [Abstract] [Full Text] [Related]
2. Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms. Nerome K, Yamaguchi R, Fuke N, Izzati UZ, Maegawa K, Sugita S, Kawasaki K, Kuroda K, Nerome R. J Gen Virol; 2018 Jul; 99(7):897-907. PubMed ID: 29877787 [Abstract] [Full Text] [Related]
3. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ. J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306 [Abstract] [Full Text] [Related]
4. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Nerome K, Sugita S, Kuroda K, Hirose T, Matsuda S, Majima K, Kawasaki K, Shibata T, Poetri ON, Soejoedono RD, Mayasari NL, Agungpriyono S, Nerome R. Vaccine; 2015 Jan 01; 33(1):117-25. PubMed ID: 25448101 [Abstract] [Full Text] [Related]
5. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І. Qian P, Zhi X, Wang B, Zhang H, Chen H, Li X. Virol J; 2015 Dec 10; 12():214. PubMed ID: 26651827 [Abstract] [Full Text] [Related]
6. Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. Hua RH, Li YN, Chen ZS, Liu LK, Huo H, Wang XL, Guo LP, Shen N, Wang JF, Bu ZG. BMC Biotechnol; 2014 Jul 10; 14():62. PubMed ID: 25011456 [Abstract] [Full Text] [Related]
8. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Wu CJ, Huang HW, Tao MH. Vaccine; 2003 Sep 08; 21(25-26):3938-45. PubMed ID: 12922129 [Abstract] [Full Text] [Related]
9. [Secreted expression of Japanese encephalitis virus prME in Pichia pastoris and immunogenicity evaluation of the virus-like particles in mice]. Zhao P, Jiang Y, Wang J, Fan H, Cao R. Sheng Wu Gong Cheng Xue Bao; 2017 May 25; 33(5):863-874. PubMed ID: 28876040 [Abstract] [Full Text] [Related]
11. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. Tajima S, Yagasaki K, Kotaki A, Tomikawa T, Nakayama E, Moi ML, Lim CK, Saijo M, Kurane I, Takasaki T. J Gen Virol; 2015 Sep 25; 96(9):2661-2669. PubMed ID: 26048886 [Abstract] [Full Text] [Related]
12. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus. Feng GH, Liu N, Zhou Y, Zhai YZ, Li XM, Dou XG. Intervirology; 2007 Sep 25; 50(2):93-8. PubMed ID: 17139185 [Abstract] [Full Text] [Related]
13. Generation and characterization of chimeric Tembusu viruses containing pre-membrane and envelope genes of Japanese encephalitis virus. Xu B, Liu X, Yan D, Teng Q, Yuan C, Zhang Z, Liu Q, Li Z. Front Microbiol; 2023 Sep 25; 14():1140141. PubMed ID: 37426013 [Abstract] [Full Text] [Related]
14. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice. Konishi E, Kurane I, Mason PW, Shope RE, Ennis FA. Virology; 1997 Jan 20; 227(2):353-60. PubMed ID: 9018134 [Abstract] [Full Text] [Related]
15. Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans. Galula JU, Chang GJ, Chuang ST, Chao DY. J Clin Microbiol; 2016 Feb 20; 54(2):412-22. PubMed ID: 26659204 [Abstract] [Full Text] [Related]
16. Allergic reactions to Japanese encephalitis vaccine. Plesner AM. Immunol Allergy Clin North Am; 2003 Nov 20; 23(4):665-97. PubMed ID: 14753386 [Abstract] [Full Text] [Related]
17. Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells. Yamaji H, Nakamura M, Kuwahara M, Takahashi Y, Katsuda T, Konishi E. Appl Microbiol Biotechnol; 2013 Feb 20; 97(3):1071-9. PubMed ID: 22948954 [Abstract] [Full Text] [Related]
18. A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection. Yang L, Xiao A, Wang H, Zhang X, Zhang Y, Li Y, Wei Y, Liu W, Chen C. Vaccines (Basel); 2022 Jan 26; 10(2):. PubMed ID: 35214656 [Abstract] [Full Text] [Related]
19. JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Chambers TJ, Droll DA, Jiang X, Wold WS, Nickells JA. Virology; 2007 Sep 15; 366(1):51-61. PubMed ID: 17521693 [Abstract] [Full Text] [Related]
20. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F. Vaccine; 1999 Apr 09; 17(15-16):1869-82. PubMed ID: 10217584 [Abstract] [Full Text] [Related] Page: [Next] [New Search]